The use of poly(I:C11-14U) for treating bacterial and protozoan infection

摘要

Disclosed is the use of poly(I:C11 -14U) in the manufacture of a medicament for the treatment of a subject with a bacterial infection or a protozoan infection. The medicament is formulated to initiate an innate immune response mediated only by Toll-Like Receptor 3 (TLR3), and activate TLR3 without activating other Toll-like receptors or RNA helicases, or without inducing an excessive amount of one or more pro-inflammatory cytokines.